SCHEMBL7056903

SCHEMBL7056903

CCC(=O)NCC(CC)c1c[nH]c2c(Cl)c(Cl)c(OC)cc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1B P49286 15/20 0.41
MTNR1A P48039 14/20 0.41
HTR2C P28335 2/20 0.39
PDE10A Q9Y233 1/20 0.34
MEN1 O00255 1/20 0.34
LMNA P02545 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
NFKB1 P19838 1/20 0.34
MAPK1 P28482 1/20 0.34
SLC6A4 P31645 1/20 0.34
CYP2C19 P33261 1/20 0.34
THPO P40225 1/20 0.34
HTR2B P41595 1/20 0.34
KMT2A Q03164 1/20 0.34
HIF1A Q16665 1/20 0.34
HDAC3 O15379 1/20 0.33
HDAC4 P56524 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7050446 0.90 MTNR1A (0.52) MTNR1BMTNR1AHTR2CPDE10AMEN1
SCHEMBL7055344 0.88 MTNR1A (0.54) MTNR1BMTNR1AHTR2C
SCHEMBL8822760 0.85 MTNR1A (0.60) MTNR1BMTNR1AHTR2CPDE10AMEN1
SCHEMBL7054074 0.83 MTNR1A (0.39) MTNR1BMTNR1A
SCHEMBL8822694 0.81 MTNR1A (0.39) MTNR1BMTNR1A
SCHEMBL7060010 0.78 MTNR1A (0.50) MTNR1BMTNR1AHTR2CHTR2B
SCHEMBL4966587 0.76 MTNR1A (0.69) MTNR1BMTNR1AMEN1LMNACYP1A2
SCHEMBL7890134 0.76 MTNR1A (0.64) MTNR1BMTNR1AMEN1LMNACYP1A2
SCHEMBL7058558 0.76 MTNR1A (0.37) MTNR1BMTNR1AHTR2CLMNACYP2C19
SCHEMBL7055066 0.75 MTNR1A (0.54) MTNR1BMTNR1AMEN1LMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0656209-B1 Melatonin derivatives for use in treating desynchronization disorders LILLY CO ELI (US) 2003-05-07 EP disclosed
EP-0655243-B1 Melatonin derivatives for use in treating sleep disorders LILLY CO ELI (US) 2002-08-21 EP disclosed
US-6180657-B1 SLEEP DISORDERS ELI LILLY AND COMPANY 2001-01-30 US disclosed
US-5770610-A ADMINISTERING R-(+)-N-(2-METHYL-2-(5-METHOXY-6-CHLOROINDOL-3-YL)ETHYL) ACETAMIDE ELI LILLY AND COMPANY (US) 1998-06-23 US disclosed
US-5654325-A Melatonin derivatives for use in treating sleep disorders ELI LILLY AND COMPANY (US) 1997-08-05 US disclosed
WO-1997000069-A1 MELATONIN AGONISTS FOR TREATING BENIGN PROSTATIC HYPERPLASIA ELI LILLY AND COMPANY (US) 1997-01-03 WO disclosed
EP-0748627-A2 Melatonin agonists for use in the treatment of benign prostatic hyperplasia ELI LILLY AND COMPANY (US) 1996-12-18 EP disclosed
EP-0656209-A2 Melatonin derivatives for use in treating desynchronization disorders ELI LILLY AND COMPANY (US) 1995-06-07 EP disclosed
EP-0655243-A2 Melatonin derivatives for use in treating sleep disorders ELI LILLY AND COMPANY (US) 1995-05-31 EP disclosed
US-4997845-A β-alkylmelatonins as ovulation inhibitors ELI LILLY AND COMPANY (US) 1991-03-05 US disclosed